 |
N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl) pyridin-2-yl) Acetamide Besylate |
|---|---|
| Trade Name | |
| Orphan Indication | Gliomas |
| USA Market Approval | USA |
| USA Designation Date | 2013-11-26 00:00:00 |
| Sponsor | Kinex Pharmaceuticals, Inc.;701 Ellicott Street;Buffalo, New York, 14203 |
